8-K: Panacea Life Sciences Dismisses BF Borgers as Independent Auditor Amid SEC Action

Panacea Life Sciences Holdings, Inc. has dismissed BF Borgers CPA PC as their independent auditor, following an SEC order that prevents BF Borgers from practicing before the commission.

Summary

• Panacea Life Sciences Holdings, Inc. dismissed BF Borgers CPA PC as their independent registered public accounting firm on May 6, 2024.
• The decision was made with the recommendation and approval of the Board of Directors.
• The company is in the process of engaging a new independent registered public accounting firm.
• BF Borgers' reports on the company's financial statements for 2022 and 2023 did not contain adverse opinions or disclaimers, except for a going concern explanatory paragraph.
• There were no disagreements with BF Borgers on accounting principles, financial statement disclosure, or auditing scope.
• The dismissal follows an SEC statement on May 3, 2024, that BF Borgers is not permitted to practice before the commission.

Sentiment

Score: 3

Explanation: The document reports a negative event (auditor dismissal due to SEC action) which raises concerns about the company's financial oversight. The company is taking steps to rectify the situation, but the overall sentiment is negative.

Positives

• The company is proactively seeking a new independent auditor.
• There were no disagreements with the previous auditor on accounting or auditing matters.

Negatives

• The dismissal of the auditor was due to an SEC order, which is a negative event for the auditor.
• The company needs to quickly find a new auditor.

Risks

• The company needs to find a new auditor quickly, which could cause delays in financial reporting.
• The SEC action against BF Borgers could raise concerns about the reliability of past audits.

Future Outlook

The company anticipates engaging a new independent registered public accounting firm quickly.

Management Comments

• The decision to change independent registered public accounting firms was made with the recommendation and approval of the Board of Directors.

Industry Context

The dismissal of an auditor due to regulatory issues is not uncommon, but it does highlight the importance of auditor independence and compliance with SEC regulations. This event may cause other companies who use BF Borgers to re-evaluate their auditor.

Comparison to Industry Standards

• The dismissal of an auditor due to regulatory issues is not uncommon, but it does highlight the importance of auditor independence and compliance with SEC regulations.
• Companies typically aim for a smooth transition when changing auditors to avoid disruptions in financial reporting.
• The fact that there were no disagreements with the previous auditor is a positive sign, but the SEC action against BF Borgers is a significant concern.

Stakeholder Impact

• Shareholders may be concerned about the reliability of past financial statements.
• The company needs to ensure a smooth transition to a new auditor to maintain investor confidence.

Next Steps

• The company will engage a new independent registered public accounting firm.

Key Dates

Keywords

auditor, BF Borgers, Panacea Life Sciences, SEC, accounting, financial statements, audit